Is Medirom Healthcare Stock a Good Investment?
Medirom Healthcare Investment Advice | MRM |
- Examine Medirom Healthcare's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Medirom Healthcare's leadership team and their track record. Good management can help Medirom Healthcare navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Providers & Services space and any emerging trends that could impact Medirom Healthcare's business and its evolving consumer preferences.
- Compare Medirom Healthcare's performance and market position to its competitors. Analyze how Medirom Healthcare is positioned in terms of product offerings, innovation, and market share.
- Check if Medirom Healthcare pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Medirom Healthcare's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Medirom Healthcare Technologies stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Medirom Healthcare Technologies is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Weak | Details | |
Volatility | Abnormally volatile | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Average | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Medirom Healthcare Stock
Researching Medirom Healthcare's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 40.0% of the company outstanding shares are owned by corporate insiders. The company had not issued any dividends in recent years.
To determine if Medirom Healthcare is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Medirom Healthcare's research are outlined below:
| Medirom Healthcare is way too risky over 90 days horizon | |
| Medirom Healthcare appears to be risky and price may revert if volatility continues | |
| Medirom Healthcare has high likelihood to experience some financial distress in the next 2 years | |
| Medirom Healthcare Technologies has 2.89 B in debt. Medirom Healthcare has a current ratio of 0.35, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Note however, debt could still be an excellent tool for Medirom to invest in growth at high rates of return. | |
| Medirom Healthcare Technologies has about 354.95 M in cash with (631.74 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 72.7, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Medirom Healthcare has a poor financial position based on the latest SEC disclosures | |
| Roughly 40.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from globenewswire.com: Mrm SCOR, MRMs reference shareholder, announced its intent to acquire all the remaining shares of MRM through a simplified public tender offer followed, if conditions are met, by a squeeze-out |
Medirom Healthcare Quarterly Cash And Short Term Investments |
|
Medirom Healthcare uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Medirom Healthcare Technologies. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Medirom Healthcare's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 29th of May 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Know Medirom Healthcare's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Medirom Healthcare is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Medirom Healthcare Technologies backward and forwards among themselves. Medirom Healthcare's institutional investor refers to the entity that pools money to purchase Medirom Healthcare's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Ubs Group Ag | 2024-06-30 | 30.0 | Bank Of America Corp | 2024-06-30 | 25.0 |
Medirom Healthcare's market capitalization trends
The company currently falls under 'Micro-Cap' category with a total capitalization of 14.91 M.Market Cap |
|
Medirom Healthcare's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.02 | 0.02 | |
| Return On Capital Employed | (0.12) | (0.13) | |
| Return On Assets | 0.02 | 0.02 | |
| Return On Equity | 0.55 | 0.57 |
Determining Medirom Healthcare's profitability involves analyzing its financial statements and using various financial metrics to determine if Medirom Healthcare is a good buy. For example, gross profit margin measures Medirom Healthcare's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Medirom Healthcare's profitability and make more informed investment decisions.
Evaluate Medirom Healthcare's management efficiency
Medirom Healthcare has Return on Asset of (0.036) % which means that on every $100 spent on assets, it lost $0.036. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 1.4695 %, implying that it generated $1.4695 on every 100 dollars invested. Medirom Healthcare's management efficiency ratios could be used to measure how well Medirom Healthcare manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Medirom Healthcare's Return On Tangible Assets are very stable compared to the past year. As of the 29th of September 2024, Return On Assets is likely to grow to 0.02, while Return On Capital Employed is likely to drop (0.13). At this time, Medirom Healthcare's Total Current Assets are very stable compared to the past year. As of the 29th of September 2024, Intangible Assets is likely to grow to about 966.7 M, though Net Tangible Assets are likely to grow to (1 B).| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 41.81 | 41.43 | |
| Tangible Book Value Per Share | (230.23) | (218.71) | |
| Enterprise Value Over EBITDA | (49.97) | (47.47) | |
| Price Book Value Ratio | 19.75 | 20.74 | |
| Enterprise Value Multiple | (49.97) | (47.47) | |
| Price Fair Value | 19.75 | 20.74 | |
| Enterprise Value | 6.9 B | 7.6 B |
The analysis of Medirom Healthcare's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Medirom Healthcare's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Medirom Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta 0.04 |
Basic technical analysis of Medirom Stock
As of the 29th of September, Medirom Healthcare secures the Mean Deviation of 6.79, risk adjusted performance of 0.0333, and Downside Deviation of 7.54. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Medirom Healthcare, as well as the relationship between them. Please verify Medirom Healthcare variance, as well as the relationship between the value at risk and skewness to decide if Medirom Healthcare Technologies is priced some-what accurately, providing market reflects its recent price of 3.02 per share. Given that Medirom Healthcare has jensen alpha of 0.1313, we recommend you to check Medirom Healthcare's last-minute market performance to make sure the company can sustain itself at a future point.Medirom Healthcare's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Medirom Healthcare insiders, such as employees or executives, is commonly permitted as long as it does not rely on Medirom Healthcare's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Medirom Healthcare insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Cohen Edward H over three months ago Disposition of 2500 shares by Cohen Edward H of Medirom Healthcare at 9.78 subject to Rule 16b-3 |
Medirom Healthcare's Outstanding Corporate Bonds
Medirom Healthcare issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Medirom Healthcare uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Medirom bonds can be classified according to their maturity, which is the date when Medirom Healthcare Technologies has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View |
Understand Medirom Healthcare's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Medirom Healthcare's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0333 | |||
| Market Risk Adjusted Performance | 0.1589 | |||
| Mean Deviation | 6.79 | |||
| Semi Deviation | 7.06 | |||
| Downside Deviation | 7.54 | |||
| Coefficient Of Variation | 3383.08 | |||
| Standard Deviation | 18.17 | |||
| Variance | 330.25 | |||
| Information Ratio | 0.0229 | |||
| Jensen Alpha | 0.1313 | |||
| Total Risk Alpha | (2.00) | |||
| Sortino Ratio | 0.0551 | |||
| Treynor Ratio | 0.1489 | |||
| Maximum Drawdown | 157.63 | |||
| Value At Risk | (11.68) | |||
| Potential Upside | 10.56 | |||
| Downside Variance | 56.91 | |||
| Semi Variance | 49.9 | |||
| Expected Short fall | (10.28) | |||
| Skewness | 6.46 | |||
| Kurtosis | 48.94 |
| Risk Adjusted Performance | 0.0333 | |||
| Market Risk Adjusted Performance | 0.1589 | |||
| Mean Deviation | 6.79 | |||
| Semi Deviation | 7.06 | |||
| Downside Deviation | 7.54 | |||
| Coefficient Of Variation | 3383.08 | |||
| Standard Deviation | 18.17 | |||
| Variance | 330.25 | |||
| Information Ratio | 0.0229 | |||
| Jensen Alpha | 0.1313 | |||
| Total Risk Alpha | (2.00) | |||
| Sortino Ratio | 0.0551 | |||
| Treynor Ratio | 0.1489 | |||
| Maximum Drawdown | 157.63 | |||
| Value At Risk | (11.68) | |||
| Potential Upside | 10.56 | |||
| Downside Variance | 56.91 | |||
| Semi Variance | 49.9 | |||
| Expected Short fall | (10.28) | |||
| Skewness | 6.46 | |||
| Kurtosis | 48.94 |
Consider Medirom Healthcare's intraday indicators
Medirom Healthcare intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Medirom Healthcare stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Medirom Healthcare Corporate Filings
6K | 24th of September 2024 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
| 18th of June 2024 Other Reports | ViewVerify | |
| 30th of April 2024 Other Reports | ViewVerify | |
| 15th of March 2024 Other Reports | ViewVerify |
Medirom Stock media impact
Far too much social signal, news, headlines, and media speculation about Medirom Healthcare that are available to investors today. That information is available publicly through Medirom media outlets and privately through word of mouth or via Medirom internal channels. However, regardless of the origin, that massive amount of Medirom data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Medirom Healthcare news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Medirom Healthcare relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Medirom Healthcare's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Medirom Healthcare alpha.
Medirom Healthcare Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Medirom Healthcare can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Additional Information and Resources on Investing in Medirom Stock
When determining whether Medirom Healthcare is a strong investment it is important to analyze Medirom Healthcare's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Medirom Healthcare's future performance. For an informed investment choice regarding Medirom Stock, refer to the following important reports:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medirom Healthcare Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medirom Healthcare. If investors know Medirom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medirom Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.582 | Earnings Share 0.15 | Revenue Per Share 1.4 K | Quarterly Revenue Growth (0.06) | Return On Assets (0.04) |
The market value of Medirom Healthcare is measured differently than its book value, which is the value of Medirom that is recorded on the company's balance sheet. Investors also form their own opinion of Medirom Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Medirom Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medirom Healthcare's market value can be influenced by many factors that don't directly affect Medirom Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Medirom Healthcare's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Medirom Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medirom Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.